Fierce Virtual Series: JPM Week 2021 has ended
Back To Schedule
Monday, January 11 • 3:45pm - 4:15pm
How responses to the 2020 pandemic could underpin accelerated improvements in patient care

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Feedback form is now closed.
In 2020, the life sciences sector mobilized at unprecedented speed to tackle the most significant health crisis facing humanity in a century. Researchers, industry and regulators collaborated to harness innovative science with some creative deal structures to develop treatments and vaccines in record time, clinicians adopted new approaches to consult and treat patients, greater sums of money, from both public and private sources, have been invested to finance these efforts. Clarivate’s Sarah Hardison and Mike Ward will discuss what lessons can be learnt that could accelerate the development of treatments for other major diseases and improve patient care.

avatar for Mike Ward

Mike Ward

Global Head of Thought Leadership, Clarivate
Mike Ward serves as Global Head of Thought Leadership at Decision Resources Group (DRG), part of Clarivate. As both an award-winning journalist and analyst, Mike has been writing, analyzing and commenting on the life sciences industry for more than 35 years. He has held editorial... Read More →
avatar for Sarah Hardison, Ph.D.

Sarah Hardison, Ph.D.

Head of Product, Regulatory & PV, Clarivate
Dr. Sarah Hardison, PhD is Head of Product, Regulatory & PV at Clarivate. Prior to joining Clarivate, Sarah worked in Product and Portfolio Management in Life Sciences companies, building great products to enable drug development pipelines. Sarah earned her PhD in Immunology... Read More →

Monday January 11, 2021 3:45pm - 4:15pm EST